Title Category Credit Event date Costsort descending
EM1909D "It’s not your thyroid… probably – Controversies in Thyroid Hormone Replacement" (IM GR091319)
  • AMA
$0.00 Hypothyroidism is one of the most commonly encountered disease states. In the Colorado Heart Study as many as 15% of women over the age of 55 had an abnormal thyroid stimulating hormone (TSH) level. The percentage of people with abnormal thyroid hormone levels continues to increase with age, with the overwhelming majority having low circulating thyroid hormone levels, or hypothyroidism. Currently in the US, approximately 123 million prescriptions for thyroid hormone replacement are dispensed, indicating how prevalent this disease state is.
EM1909E "From the Ocean Depths to the Mountain Tops: How do Humans Adapt" (IM GR-092019)
  • AMA
$0.00 This presentation will describe the physiological changes associated with diving & immersion, and altitude exposure. Medical complications of each type of exposure will also be presented.
Psychiatry Master Class Series: Unlocking Mental Illness (RP2008A)
  • AMA
  • Attendance
$0.00 This series of classes is designed for advanced level mental health practitioners at a post-licensure level. The 6-hour Saturday classes will present the latest information in psychiatric treatment, coupled with hands-on practice and direct observation. All classes will be taught by expert faculty to a maximum of 25 participants who wish to advance their professional practice through the acquisition and mastery of very specific skills. Participants can register for and attend a single class, or the entire series.
EM1910H "Tools to Improve Survival in Dialysis: Doing the Most with a Half-Way Technology" (IM GR-100419)
  • AMA
$0.00 Nearly all healthcare professionals will encounter patients with end-stage renal disease. This lecture will discuss how to optimally manage these patients in order to increase their survival. Download Protocol
Acute Liver Failure: Science and Practice (RP2003B)
  • AMA
  • Attendance
03/30/2020 $0.00 Acute liver failure (ALF) is a rare but devastating condition that arises from diverse etiologies, has a high mortality and requires high resource utilization including transplantation.
Marybeth Ezaki/Peter Carter Visiting Professorship 2019 (JS1910E)
  • AMA
  • Attendance
10/11/2019 $0.00 This symposium will discuss recent developments and advances in the area of pediatric upper extremity surgery, identify management options for a variety of upper extremity conditions, and discuss treatment options for radial polydactyly, triphalangeal thumb, and radial longitudinal deficiency.
EM1910I "Immunotherapy in Lung Cancer Treatment: A New Paradigm Still in Revision" (IM GR-101119)
  • AMA
$0.00 To discuss changing paradigms in the treatment of advanced lung cancer with immune checkpoint blockade. Antibodies against inhibitory T cell immune check¬points have now become standard of treatment in the first- and second-line therapies for meta¬static lung cancer. We will review the role of T cell immune check points in tumor biology, a brief overview of the clinical data of immune checkpoint inhibitors, attempts to identify predictive bio¬markers, and a discussion of immune related adverse events from T cell checkpoint blockade.
More Remissions, More Often: Getting the Best Outcomes from Therapeutic Repetitive Transcranial Magnetic Stimulation (rTMS) (RP1911F)
  • AMA
  • Attendance
11/15/2019 $0.00 Major depressive disorder is a serious, debilitating illness that affects individuals of all ages and backgrounds. While several efficacious treatments have been developed, many suffering from depression fail to reach full remission and experience lifelong challenges due to the chronic and episodic nature of the disease. Identifying strategies to find the right treatments for patients is critical.One novel treatment that has gained recent popularity is Transcranial Magnetic Stimulation (TMS), a form of neurostimulation.
Dallas Advanced Heart Failure Symposium: State-of-the-Art Update on Mechanical Circulatory Support (RP2002C)
  • AMA
  • Attendance
02/29/2020 $40.00 OVERVIEWContinuous flow left ventricular assist devices (LVADs) have changed the natural history of individuals with end-stage advanced heart failure. Since their regulatory approval in 2008, there have been substantial improvements in LVAD technology, management, and understanding of prognosis.
UT Southwestern - Texas Health Resources Annual Cardiovascular Symposium (RP1910C)
  • AMA
  • Attendance
10/26/2019 $50.00 Click Here to View Full AgendaBE SURE TO NOTE OUR NEW SOUTH CAMPUS LOCATION: UT Southwestern Medical Center / 5323 Harry Hines Blvd. (D1.600 Lecture Hall) / Dallas, TX

Pages